Assessment of immune activation in mice before and after eradication of mite infestation

Journal of the American Association for Laboratory Animal Science

Volumn 48, Issue 4, 2009, Pages 371-377

  Johnston, Nancy A ^a   Trammell, Rita A ^a   Ball Kell, Susan ^b   Verhulst, Steven ^a   Toth, Linda A ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; REVOLUTION; SELAMECTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACANTHOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXILLARY LYMPH NODE; CONTROLLED STUDY; CYTOKINE RELEASE; DERMIS; EPIDERMIS; ERADICATION THERAPY; FEMALE; HISTOPATHOLOGY; HYPERKERATOSIS; IMMUNOSTIMULATION; INFESTATION; LYMPHATIC DRAINAGE; MALE; MOUSE; NONHUMAN; PARAKERATOSIS; SKIN; SKIN INFLAMMATION; SPLEEN; SUBCUTANEOUS TISSUE;

ANIMALS; CHEMOKINES; CYTOKINES; FEMALE; HOUSING, ANIMAL; IMMUNE SYSTEM; INSECTICIDES; LYMPH NODES; MALE; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MITE INFESTATIONS; MITES; RODENT DISEASES; SKIN; SPLEEN;

ACARI; MUS;

EID: 69549090180     PISSN: 15596109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Abbas AK, Lichtman AH. 2005. Cellular and molecular immunology. Philadelphia (PA): Elsevier Saunders.
2. Baker DG. 1998. Natural pathogens of laboratory mice, rats, and rabbits and their effect on research. Clin Microbiol Rev 11:231-266.
3. Bartke A. 2008. Personal communication.
4. Bartke A, Masternak MM, Al-Regaiey KA, Bonkowski MS. 2007. Effects of dietary restriction on the expression of insulin-signaling-related genes in long-lived mutant mice. Interdiscip Top Gerontol 35:69-82.
5. Baumans V, Havenaar R, Van Herck H. 1988. The use of repeated treatment with Ivomec and Neguvon spray in the control of murine fur mites and oxyurid worms. Lab Anim 22:246-249. (Pubitemid 18192905)
6. Baumans V, Havenaar R, Van Herck H, Rooymans TP. 1988. The effectiveness of Ivomec and Neguvon in the control of murine mites. Lab Anim 22:243-245. (Pubitemid 18192904)
7. Bean-Knudsen DE, Wagner JE, Hall RD. 1986. Evaluation of the control of Myobia musculi infestations on laboratory mice with permethrin. Lab Anim Sci 36:268-270.
8. Blakley BR, Rousseaux CG. 1991. Effect of ivermectin on the immune response in mice. Am J Vet Res 52:593-595.
9. Bornstein DA, Scola J, Rath A, Warren HB. 2006. Multimodal approach to treatment for control of fur mites. J Am Assoc Lab Anim Sci 45:29-32. (Pubitemid 44162745)
10. Burdett EC, Heckmann RA, Ochoa R. 1997. Evaluation of five treatment regimens and five diagnostic methods for murine mites (Myocoptes musculinus and Myobia musculi). Contemp Top Lab Anim Sci 36:73-76. (Pubitemid 127525128)
11. Chu DK, Couto MA. 2005. Arthropod infestation in a colony of mice. Lab Anim (NY) 34:25-27.
12. Cole JS, Sabol-Jones M, Karolewski B, Byford T. 2005. Ornithonyssus bacoti infestation and elimination from a mouse colony. Contemp Top Lab Anim Sci 44:27-30. (Pubitemid 41339023)
13. Conole J, Wilkinson MJ, McKellar QA. 2003. Some observations on the pharmacological properties of ivermectin during treatment of a mite infestation in mice. Contemp Top Lab Anim Sci 42:42-45. (Pubitemid 37099569)
14. Csiza CK, McMartin DN. 1976. Apparent acaridal dermatitis in a C57BL/6 Nya mouse colony. Lab Anim Sci 26:781-787.
15. Dawson DV, Whitmore SP, Bresnahan JF. 1986. Genetic control of susceptibility to mite-associated ulcerative dermatitis. Lab Anim Sci 36:262-267.
16. Fick JL, Novo RE, Kirchhof N. 2005. Comparison of gross and histologic tissue responses of skin incisions closed by use of absorbable subcuticular staples, cutaneous metal staples, and ployglactin 910 suture in pigs. Am J Vet Res 66:1975-1984. (Pubitemid 43091722)
17. Fraser J, Joiner GN, Jardine JH. 1974. The use of pelleted dichlorvos in the control of murine acariasis. Lab Anim 8:271-274.
18. French AW. 1987. Elimination of Ornithonyssus bacoti in a colony of aging mice. Lab Anim Sci 37:670-672.
19. Friedman S, Weisbroth SH. 1975. The parasitic ecology of the rodent mite Myobia musculi. II. Genetic factors. Lab Anim Sci 25:440-445.
20. Friedman S, Weisbroth SH. 1977. The parasitic ecology of the rodent mite, Myobia musculi. IV. Life cycle. Lab Anim Sci 27:34-37.
21. Goncalves Dasilva A, Yong VW. 2009. Matrix metalloproteinase-12 deficiency worsens relapsing-remitting experimental autoimmune encephalomyelitis in association with cytokine and chemokine dysregulation. Am J Pathol 174:898-909.
22. Gonenc B, Sarimehmetoglu HO, Ica A, Kozan E. 2006. Efficacy of selamectin against mites (Myobia musculi, Myocoptes musculinus, and Radfordia ensifera) and nematodes (Aspiculuris tetraptera and Syphacia obvelata) in mice. Lab Anim 40:210-213.
23. Green CJ, Needham JR. 1974. Control of mange mites in a large mouse colony. Lab Anim 8:245-251.
24. Hill WA, Randolph MM, Boyd KL, Mandrell TD. 2005. Use of permethrin eradicated the tropical rat mite (Ornithonyssus bacoti) from a colony of mutagenized and transgenic mice. Contemp Top Lab Anim Sci 44:31-34.
25. Huerkamp MJ, Zitzow LA, Webb S, Pullium JK. 2005. Cross-fostering in combination with ivermectin therapy: a method to eradicate murine fur mites. Contemp Top Lab Anim Sci 44:12-16. (Pubitemid 41040561)
26. Hultcrantz M, Jacobson S, Hill NJ, Santamaria P, Flodström-Tullberg M. 2009. The target cell response to cytokines governs the autoreactive T cell repertoire in the pancreas of NOD mice. Diabetologia 52:299-305.
27. Iijima OT, Takeda H, Komatsu Y, Matsumiya T, Takahashi H. 2000. Atopic dermatitis in NC/Jic mice associated with Myobia musculi infestation. Comp Med 50:225-228. (Pubitemid 30227820)
28. Jackson TA, Boivin GP, Hall JE, Luo W, Stedelin JR. 1997. Ivermectin toxicosis in mice of multiple transgenic lines. Contemp Top Lab Anim Sci 36:77.
29. Jacoby RO, Fox JG, Davisson M. 2002. Biology and diseases of mice, p 35-120. In: Fox JG, Anderson LC, Loew FM, Quimby FW, editors. Laboratory animal medicine. New York (NY): Academic Press.
30. Jungmann P, Freitas A, Bandeira A, Nobrega A, Coutinho A, Marcos M-A, Minoprio P. 1996. Murine acariasis. II. Immunological dysfunction and evidence for chronic activation of Th2 lymphocytes. Scand J Immunol 43:604-612. (Pubitemid 26166280)
31. Jungmann P, Guenet J-L, Cazenave P-A, Cazenave P-A, Coutinho A, Huerre M. 1996. Murine acariasis: I. Pathological and clinical evidence suggesting cutaneous allergy and wasting syndrome in BALB/c mouse. Res Immunol 147:27-38.
32. Kalishman J. 2007. Selamectin treatment for mice. Personal communication.
33. Kobayashi Y. 2006. Neutrophil infiltration and chemokines. Crit Rev Immunol 26:307-316.
34. Kobayashi Y. 2008. The role of chemokines in neutrophil biology. Front Biosci 13:2400-2407.
35. Kondo S, Taylor A, Chun S. 1998. Elimination of an infestation of rat fur mites (Radfordia ensifera) from a colony of Long Evans rats, using the microdot technique for topical administration of 1% ivermectin. Contemp Top Lab Anim Sci 37:58-61. (Pubitemid 128531025)
36. Laltoo H, Kind LS. 1979. Reduction of contact sensitivity reactions to oxazolone mite-infested mice. Infect Immun 26:30-35. (Pubitemid 10248627)
37. Laltoo H, Van Zoost T, Kind LS. 1979. IgE antibody response to mite antigens in mite-infested mice. Immunol Commun 8:1-9. (Pubitemid 9143365)
38. Lee JD, Huh JE, Baek YH, Cho KC, Choi DY, Park DS. 2009. The efficacy and mechanism action of RvCSd, a new herbal agent, on immune suppression and cartilage protection in a mouse model of rheumatoid arthritis. J Pharmacol Sci 109:211-221.
39. Levee EM, Klinger MM, Kaiser CC, Serrano LJ. 1994. A practical delivery method for oral administration of ivermectin to large colonies of rodents. Contemp Top Lab Anim Sci 33:68-70.
40. Levine JF, Lage AL. 1984. House mouse mites infesting laboratory rodents. Lab Anim Sci 34:393-394.
41. Mather TN, Lausen NCG. 1990. A new insecticide delivery method for control of fur mite infestations in laboratory mice. Lab Anim 9:25-29.
42. Mehlhorn H, Schmahl G, Mevissen I. 2005. Efficacy of a combination of imidacloprid and moxidectin against parasites of reptiles and rodents: case reports. Parasitol Res 97:S97-S101. (Pubitemid 41446654)
43. Mook DM, Benjamin KA. 2008. Use of selamectin and moxidectin in the treatment of mouse fur mites. J Am Assoc Lab Anim Sci 47:20-24.
44. Monta E, Kaneko S, Hiragun T, Shindo H, Tanaka T, Furukawa T, Nobukiyo A, Yamamoto S. 1999. Fur mites induce dermatitis associated with IgE hyperproduction in an inbred strain of mice, NC/Kuj. J Dermatol Sci 19:37-43. (Pubitemid 28552869)
45. National Research Council. 1991. Infectious diseases of mice and rats: a report of the Institute of Laboratory Animal Resources Committee on Infectious Diseases of Mice and Rats. Washington (DC): National Academy Press.
46. Papini R, Marconcini A. 1991. Treatment with ivermectin in drinking water against Myobia musculi and Myocoptes musculinus mange in naturally infected laboratory mice. Angew Parasitol 32:11-13.
47. Pence BC, Demick DS, Richard BC, Buddingh F. 1991. The efficacy and safety of chlorpyrifos (Dursban) for control of Myobia musculi infestation in mice. Lab Anim Sci 41:139-142.
48. Pochanke V, Hatak S, Hengartner H, Zinkemagel RM, McCoy KD. 2006. Induction of IgE and allergic-type responses in fur mite-infested mice. Eur J Immunol 36:2434-2445. (Pubitemid 44420600)
49. Pollicino P, Rossi L, Rambozzi L, Farca AM, Peano A. 2008. Oral administration of moxidectin for treatment of murine acariasis due to Radfordia affinis. Vet Parasitol 151:355-357.
50. Pullium JK, Brooks WJ, Langley AD, Huerkamp MJ. 2005. A single dose of topical moxidectin as an effective treatment for murine acariasis due to Myocoptes musculinus. Contemp Top Lab Anim Sci 44:26-28.
51. Sebesteny A. 1991. Necessity of a more standardized microbial characterization of rodents for aging studies. Neurobiol Aging 12:663-668.
52. Seeger H, Wallwiener D, Mueck AO. 2008. Effects of estradiol and progestogens on tumor-necrosis factor α-induced changes of biochemical markers for breast cancer growth and metastasis. Gynecol Endocrinol 24:576-579.
53. Skopets B, Wilson RP, Griffith JW, Lang CW. 1996. Ivermectin toxicity in young mice. Lab Anim Sci 46:111-112.
54. Sundburg JP, King LE Jr. 2000. Skin and its appendages: normal anatomy and pathology of spontaneous, transgenic, and targeted mouse mutations, p 183-215. In: Ward JM, Mahler JF, Maronpot RR, Sundberg JP, editors. Pathology of genetically engineered mice. Ames (IA): Iowa State University Press.
55. Toth LA, Oberbeck C, Straign CM, Frazier S, Rehg JE. 2000. Toxicity evaluation of prophylactic treatments for mites and pinworms in mice. Contemp Top Lab Anim Sci 39:18-21.
56. Uchi H, Terao H, Koga T, Furue M. 2000. Cytokines and chemokines in the epidermis. J Dermatol Sci 24:S29-S38.
57. Vachon P, Aubry L. 1996. [The use of ivermectin for the treatment of mites, Myobia musculi and Mycoptes musculinus, in a colony of transgenic mice.] Article in French. Can Vet J 37:231-232.
58. Van der Meide PH, Schellekens H. 1996. Cytokines and the immune response. Biotherapy 8:243-249.
59. Wagner JE. 1969. Control of mouse ectoparasites with resin vaporizer strips containing Vapona. Lab Anim Care 19:804-807.
60. Wagner JE, Johnson DR. 1970. Toxidty of dichlorvos for laboratory mice - LD50 and effect on serum Cholinesterase. Lab Anim Care 20:45-47.
61. Watson DP. 1961. The effect of the mite Myocoptes musculinus (CL Koch 1840) on the skin of the white laboratory mouse and its control. Parasitology 51:373-378.
62. Watson J. 2008. New building, old parasite: mesostigmatid mites,- an ever-present threat to barrier facilities. ILAR J 49:303-309.
63. Weisbroth SH, Friedman S, Powell M, Scher S. 1974. The parasitic ecology of the rodent mite Myobia musculi. I. Grooming factors. Lab Anim Sci 24:510-516.
64. Weisbroth SH, Friedman S, Scher S. 1976. The parasitic ecology of the rodent mite, Myobia musculi. III. Lesions in certain host strains. Lab Anim Sci 26:725-735.
65. Welter A, Mineo JR, de Oliveira Silva DA, Lourenco EV, Vieira Ferro EA, Roque-Barreira MC, Maria da Silva N. 2007. BALB/c mice resistant to Toxoplasma gondii infection proved to be highly susceptible when previously infected with Myocoptes musculinus fur mites. Int J Exp Pathol 88:325-335. (Pubitemid 47416541)
66. Welter A, Mineo JR, Silva DA, Lourenco EV, Ferro EA, Roque-Barreira MC, da Silva NM. 2006. An opposite role is exerted by the acarian Myocoptes musculinus in the outcome of Toxoplasma gondii infection according to the route of the protozoa inoculation. Microbes Infect 8:2618-2628. (Pubitemid 44592641)
67. West WL, Schofield JC, Bennett BT. 1992. Efficacy of the 'microdot' technique for administering topical 1% ivermectin for the control of pinworms and fur mites in mice. Contemp Top Lab Anim Sci 31:7-10.
68. Winchester M, Farrell B, Hayes Y, Bellinger D. 2004. The use of fipronil (Frontline) and selamectin (Revolution) for the treatment and control of parasites in mice. Contemp Top Lab Anim Sci 43:65.
69. Wing SR, Courtney CH, Young MD. 1985. Effect of ivermectin on murine mites. J Am Vet Med Assoc 187:1191-1192.
70. Yamaguchi T, Maekawa T, Nishikawa Y, Nojima H, Kaneko M, Kawakita T, Miyamoto T, Kuraishi Y. 2001. Characterization of itch-associated responses of NC mice with mite-induced chronic dermatitis. J Dermatol Sci 25:20-28. (Pubitemid 32012642)